NovMetaPharma Co., Ltd. (XKON:229500)
9,800.00
+350.00 (3.70%)
At close: Apr 2, 2026
-4.85% (1Y)
| Market Cap | 125.85B +110.7% |
| Revenue (ttm) | 1.30B +21.4% |
| Net Income | 408.03M |
| EPS | 120.00 |
| Shares Out | 12.84M |
| PE Ratio | 81.67 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,843 |
| Average Volume | 7,186 |
| Open | 9,600.00 |
| Previous Close | 9,450.00 |
| Day's Range | 9,440.00 - 9,990.00 |
| 52-Week Range | 6,580.00 - 17,890.00 |
| Beta | 0.19 |
| RSI | 58.58 |
| Earnings Date | n/a |